Maheshwari Logi. (MAHESHWARI)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price ₹50.08 is 29% below book value of ₹70.25, offering a clear margin of safety on assets.
• P/E of 6.52 and PEG of 0.25 with 38.87% profit growth indicate a very low earnings-relative valuation.
• Piotroski F-Score of 7/9 shows improving fundamentals in profitability, leverage, or efficiency.
• Sales growth of 13.68% demonstrates business expansion.
• Promoter holding of 56.58% aligns management interests with minority shareholders.

Concerns

• Debt-to-equity of 1.45 is high for a low-margin diversified company, increasing financial fragility.
• Latest quarter net profit of ₹4 Cr on sales of ₹262 Cr implies a razor-thin ~1.5% net margin.
• No dividend (0.00% yield), so shareholders rely entirely on capital appreciation or asset monetisation.
• ROE is not reported; combined with 'diversified' industry, this raises questions about capital allocation and true returns.

AI Analysis

When I see a stock at ₹50.08 against a book value of ₹70.25—a 29% discount—and a P/E of just 6.52, my Graham instincts stir. Add a Piotroski score of 7 out of 9 and sales growth of 13.68%, and it looks like Mr. Market is handing me a margin of safety. Profit growth of 38.87% brings the PEG to 0.25, so the valuation does not demand much. But let me slow down. The latest quarter earned ₹4 Cr on ₹262 Cr of sales—a net margin of about 1.5%. That is a hair-thin cushion. With debt-to-equity at 1.45, a small stumble in revenue or rise in interest costs could wipe out a large share of earnings. ROCE of 12.62% is acceptable, but it is not a wonderful franchise. Promoters own 56.58%, which aligns interests, yet they pay no dividend. I cannot call this a business I understand deeply enough to hold forever; 'diversified' often hides mediocre capital allocation. The cheap price reflects cyclical fragility, not a quality moat. If the balance sheet is sound and leverage steadily falls, this could be an asset-backed bargain. But with ROE not disclosed and a leveraged balance sheet, I would keep the position small and watch it closely. Rather than buy on faith, I would wait for better disclosure or a further margin of safety. The numbers are tempting, but as Buffett says: it's far better to buy a wonderful business at a fair price than a fair business at a wonderful price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer